PHGE — Biomx Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro CapNeutral
- $11.71m
- -$14.07m
- 29
- 52
- 20
- 24
Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.001 | 0.347 | -30.1 | -36.2 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | — | -0.881 | 3.01 | 2.98 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.001 | 0.33 | 0.453 | 3.1 |
Change in Accounts Receivable | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -0 | -0.205 | -24.4 | -27.6 |
Capital Expenditures | — | — | -1.01 | -3.68 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | -70 | -9.85 | 19.9 |
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Change in Net Investments | ||||
Purchase of Investments | ||||
Cash from Investing Activities | — | -70 | -10.9 | 16.2 |
Financing Cash Flow Items | -0.025 | 0.241 | -0.075 | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0 | 70.9 | 0.134 | 37.3 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0 | 0.696 | -35.2 | 25.9 |